文献

J-GLOBAL ID：200902289130859030   整理番号：05A0749846

HCV1b+ HLA-A24+患者における細胞性および液性免疫系の両方で認めたC型肝炎ウイルス1b誘導ペプチドの同定

Identification of hepatitis C virus 1b-derived peptides recognized by both cellular and humoral immune systems in HCV1b⁺ HLA-A24⁺ patients

著者 (13件)： TAMURA Mayumi (Dep. of Immunology, Kurume Univ. School of Medicine, Kurume, Fukuoka 830-0011, JPN) ,  YAMADA Akira (Dep. of Immunology, Kurume Univ. School of Medicine, Kurume, Fukuoka 830-0011, JPN) ,  YAMADA Akira (Kurume Univ. Res. Center for Innovative Cancer Therapy, and Center of the 21st Century COE Program for Medical Sci. ...) ,  TAKAO Yukari (Dep. of Immunology, Kurume Univ. School of Medicine, Kurume, Fukuoka 830-0011, JPN) ,  TAKAO Yukari (Dep. of Internal Medicine, Kurume Univ. School of Medicine, Kurume, Fukuoka 830-0011, JPN) ,  MATSUEDA Satoko (Dep. of Immunology, Kurume Univ. School of Medicine, Kurume, Fukuoka 830-0011, JPN) ,  KOMATSU Nobukazu (Dep. of Immunology, Kurume Univ. School of Medicine, Kurume, Fukuoka 830-0011, JPN) ,  KOMATSU Nobukazu (Kurume Univ. Res. Center for Innovative Cancer Therapy, and Center of the 21st Century COE Program for Medical Sci. ...) ,  YUTANI Shigeru (Dep. of Immunology, Kurume Univ. School of Medicine, Kurume, Fukuoka 830-0011, JPN) ,  IDE Tatsuya (Dep. of Internal Medicine, Kurume Univ. School of Medicine, Kurume, Fukuoka 830-0011, JPN) ,  SATA Michio (Dep. of Internal Medicine, Kurume Univ. School of Medicine, Kurume, Fukuoka 830-0011, JPN) ,  ITOH Kyogo (Dep. of Immunology, Kurume Univ. School of Medicine, Kurume, Fukuoka 830-0011, JPN) ,  ITOH Kyogo (Kurume Univ. Res. Center for Innovative Cancer Therapy, and Center of the 21st Century COE Program for Medical Sci. ...)
資料名： Hepatology Research  (Hepatology Research)
巻： 32  号： 4  ページ： 227-234  発行年： 2005年08月 
JST資料番号： W1284A  ISSN： 1386-6346  資料種別： 逐次刊行物 (A)
記事区分： 原著論文  発行国： オーストラリア (AUS)  言語： 英語 (EN)

抄録/ポイント： 科学の進歩にもかかわらず,C型肝炎ウイルス(HCV)のための...

シソーラス用語： ヒト ,...
準シソーラス用語： HCV1b ,...

   続きはJDreamIII（有料）にて  {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=05A0749846&from=J-GLOBAL&jstjournalNo=W1284A") }}

分類 (2件)： 消化器疾患の治療一般  (GH05010V) ,  蛋白質・ペプチド一般  (EB03010N)

引用文献 (18件)：

• World Health Organization. Hepatitis C gloval prevalence (update). World Health Org Wkly Epidemil Rec. 2000, 75, 18-19
• KATO, N. Molecular cloning of the human hepatitis C virus genome from Japanese patients with non-A, non-B hepatitis. Proc Natl Acad Sci USA. 1990, 87, 9524-9528
• BLATT, LM. Assessment of hepatitis C virus RNA and genotype from 6807 patients with chronic hepatitis C in the United States. J Viral Hepat. 2000, 7, 196-202
• TAKAO, Y. Antibody reactive to a hepatitis C virus (HCV)-derived peptide capable of including HLA-A2 restricted cytotoxic T lymphocytes is detectable in the majority of HCV-infected individuals without HLA-A2 restriction. Microbiol Immunol. 2004, 48, 507-517
• ITO, M. Identification of SRAT3-derived peptides capable of inducing HLA-A24-restricted and tumor-specific CTLs in cancer patients with different HLA-A24 subtypes. Int J Cancer. 2000, 88, 633-639

タイトルに関連する用語 (7件)： 患者 ,  細胞性 ,  液性免疫 ,  C型肝炎ウイルス1b ,  誘導 ,  ペプチド ,  同定